Eam Investors, LLC Kala Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $1.9 Million - $2.81 Million	-253,352 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $432,768 - $716,431	51,953 Added 25.8%	253,352 $2.66 Million
Q1 2020 May 13, 2020	BUY	$3.83 - $8.79 $771,358 - $1.77 Million	201,399 New	201,399 $1.77 Million
Q4 2017 Feb 12, 2018	SELL	$13.68 - $23.17 $810,102 - $1.37 Million	-59,218 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$19.86 - $26.53 $1.18 Million - $1.57 Million	59,218	59,218 $1.35 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.